Latest News about RARE
Recent news which mentions RARE
Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study
April 15, 2024
From Benzinga
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
From Benzinga
Analyst Scoreboard: 8 Ratings For Ultragenyx Pharmaceutical
March 18, 2024
Tickers
RARE
From Benzinga
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
February 15, 2024
Tickers
RARE
From Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
From Benzinga
4 Analysts Have This To Say About Ultragenyx Pharmaceutical
January 19, 2024
Tickers
RARE
From Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 19, 2023
From Benzinga
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
October 19, 2023
From Benzinga
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 18, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
From Benzinga
Why Is Mereo BioPharma Stock Trading Higher Today?
October 16, 2023
From Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
October 10, 2023
Tickers
RARE
From Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
From Benzinga
Meta’s stock deemed a high-conviction buy at Citi, as strategy remains ‘underappreciated’
June 09, 2023
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.